BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31025779)

  • 1. Subregional differences in astrocytes underlie selective neurodegeneration or protection in Parkinson's disease models in culture.
    Kostuk EW; Cai J; Iacovitti L
    Glia; 2019 Aug; 67(8):1542-1557. PubMed ID: 31025779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson's disease.
    Kostuk EW; Cai J; Iacovitti L
    J Neuroinflammation; 2018 May; 15(1):139. PubMed ID: 29751760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aquaporin-4 deficiency diminishes the differential degeneration of midbrain dopaminergic neurons in experimental Parkinson's disease.
    Zhang J; Yang B; Sun H; Zhou Y; Liu M; Ding J; Fang F; Fan Y; Hu G
    Neurosci Lett; 2016 Feb; 614():7-15. PubMed ID: 26748031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cell derived dopaminergic subpopulations model the selective neuron degeneration in Parkinson's disease.
    Oosterveen T; Garção P; Moles-Garcia E; Soleilhavoup C; Travaglio M; Sheraz S; Peltrini R; Patrick K; Labas V; Combes-Soia L; Marklund U; Hohenstein P; Panman L
    Stem Cell Reports; 2021 Nov; 16(11):2718-2735. PubMed ID: 34678205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of cultured dopamine neurons from MPP(+) requires a combination of neurotrophic factors.
    Jaumotte JD; Wyrostek SL; Zigmond MJ
    Eur J Neurosci; 2016 Jul; 44(1):1691-9. PubMed ID: 27098376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective increase of in vivo firing frequencies in DA SN neurons after proteasome inhibition in the ventral midbrain.
    Subramaniam M; Kern B; Vogel S; Klose V; Schneider G; Roeper J
    Eur J Neurosci; 2014 Sep; 40(6):2898-909. PubMed ID: 25059097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactive astrocytes are key players in nigrostriatal dopaminergic neurorepair in the MPTP mouse model of Parkinson's disease: focus on endogenous neurorestoration.
    'Episcopo FL; Tirolo C; Testa N; Caniglia S; Morale MC; Marchetti B
    Curr Aging Sci; 2013 Feb; 6(1):45-55. PubMed ID: 23895521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gremlin is a novel VTA derived neuroprotective factor for dopamine neurons.
    Phani S; Jablonski M; Pelta-Heller J; Cai J; Iacovitti L
    Brain Res; 2013 Mar; 1500():88-98. PubMed ID: 23348379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K-ATP channels promote the differential degeneration of dopaminergic midbrain neurons.
    Liss B; Haeckel O; Wildmann J; Miki T; Seino S; Roeper J
    Nat Neurosci; 2005 Dec; 8(12):1742-51. PubMed ID: 16299504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hTH-GFP reporter rat model for the study of Parkinson's disease.
    Iacovitti L; Wei X; Cai J; Kostuk EW; Lin R; Gorodinsky A; Roman P; Kusek G; Das SS; Dufour A; Martinez TN; Dave KD
    PLoS One; 2014; 9(12):e113151. PubMed ID: 25462571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria.
    Cheng XY; Biswas S; Li J; Mao CJ; Chechneva O; Chen J; Li K; Li J; Zhang JR; Liu CF; Deng WB
    Transl Neurodegener; 2020 Apr; 9(1):13. PubMed ID: 32345341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
    Harrison IF; Anis HK; Dexter DT
    Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.
    Maingay M; Romero-Ramos M; Carta M; Kirik D
    Neurobiol Dis; 2006 Sep; 23(3):522-32. PubMed ID: 16806952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson's disease pathogenesis.
    Burke WJ; Li SW; Williams EA; Nonneman R; Zahm DS
    Brain Res; 2003 Nov; 989(2):205-13. PubMed ID: 14556942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VGLUT2 Is a Determinant of Dopamine Neuron Resilience in a Rotenone Model of Dopamine Neurodegeneration.
    Buck SA; De Miranda BR; Logan RW; Fish KN; Greenamyre JT; Freyberg Z
    J Neurosci; 2021 Jun; 41(22):4937-4947. PubMed ID: 33893220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
    Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
    eNeuro; 2017; 4(6):. PubMed ID: 29177188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.
    Brichta L; Greengard P
    Front Neuroanat; 2014; 8():152. PubMed ID: 25565977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary culture.
    Wiemerslage L; Schultz BJ; Ganguly A; Lee D
    J Neurochem; 2013 Aug; 126(4):529-40. PubMed ID: 23452092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.